BioShares Biotechnology Clinical Trials ETF (BBC) ETF

Expense Ratio: 0.79% | AUM: 49.62M | Issuer: BioShares

BBC Daily Price Range
BBC 52-Week Price Range

BBC - Real-Time SMART Grade™

A
Strong Buy

Overall SMART Grade

BBC has a real-time SMART Grade of A (Strong Buy).

Learn More About SMART Grades™

BBC - Profile & Info


The investment objective of the Virtus LifeSci Biotech Clinical Trials ETF seeks investment results that correspond to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. The clinical trials index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development.

Issuer BioShares
Expense Ratio 0.79%
Assets Under Management (AUM) 49.62M
Underlying Index BioShares Biotechnology Clinical Trials Index
Asset Class Portfolio-Multi Asset
ETF Category Health & Biotech ETFs
Net Asset Value (NAV) $43.15
Options? Yes
Total Holdings 133

BBC - Top Holdings

Symbol Holding Name % of Total
NVAX Novavax Inc 1.23%
ATRA Atara Biotherapeutics 1.12%
SRNE Sorrento Therapeutics Inc 1.05%
DVAX DYNAVAX TECHNO 1.02%
MGNX MacroGenics Inc 1.01%
OVID Ovid Therapeutics Inc 0.98%
AKRO Akero Therapeutics Inc 0.96%
ARWR Arrowhead Pharmaceutical 0.95%
GERN Geron Corp 0.93%
DRNA DICERNA PHARMA 0.93%
BNTX BioNTech SE 0.93%
CRSP CRISPR Therapeutics AG 0.92%
SYRS Syros Pharmaceuticals Inc 0.91%
RAPT RAPT Therapeutics Inc 0.90%
GTHX G1 Therapeutics Inc 0.90%
APRE Aprea Therapeutics Inc 0.89%
BCEL Atreca Inc 0.89%
ITCI Intra-Cellular Therapies Inc 0.88%
ARQT ARCUTIS BIOTHERAPEUTICS 0.87%
BDTX BLACK DIAMOND THERAPEUTI 0.87%
ANAB Anaptys Bio Inc 0.87%
MEIP MEI Pharma Inc 0.86%
CRBP Corbus Pharmaceuticals Holdings Inc 0.85%
MYOV Myovant Sciences Ltd 0.84%
KNSA Kiniksa Pharmaceuticals Ltd 0.83%
TGTX TG Therapeutics Inc 0.83%
CARA Cara Therapeutics Inc 0.83%
FATE FATE THERAPEUTIC 0.82%
TBIO Translate Bio Inc 0.82%
AMRS Amyris Inc 0.82%
AXSM AXME THERAPUTI 0.81%
VIR Vir Biotechnology Inc 0.81%
AKBA Akebia Therapeutics Inc 0.81%
AGEN Agenus Inc 0.81%
MRTX Mirati Therapeutics Inc 0.81%
IGMS IGM Biosciences Inc 0.81%
KRTX Karuna Therapeutics Inc 0.80%
BCRX BioCryst Pharmaceuticals Inc 0.80%
EDIT EDITAS MEDICIN 0.80%
WVE WAVE Life Sciences Ltd 0.80%
MRSN Mersana Therapeutics Inc 0.80%
NTLA Intellia Therapeutics Inc 0.80%
FREQ FREQUENCY THERAPEUTICS 0.79%
RCKT Rocket Pharmaceuticals Inc 0.79%
ATNX Athenex 0.79%
BTAI BioXcel Therapeutics Inc 0.79%
MIRM Mirum Pharmaceuticals Inc 0.79%
XNCR Xencor Inc 0.79%
ODT Odonate Therapeutics Inc 0.79%
DTIL Precision BioSciences Inc 0.79%
MRNS Marinus Pharmaceuticals Inc 0.78%
ASMB Assembly Biosciences Inc 0.78%
CVM CEL-SCI Corp 0.78%
CRNX Crinetics Pharmaceuticals Inc 0.78%
CYTK Cytokinetics Inc 0.78%
FGEN FibroGen Inc. 0.77%
RGNX Regenxbio Inc 0.77%
VYGR Voyager Therapeutics Inc 0.77%
BHVN Biohaven Pharmaceutical Holding Co. Ltd. 0.77%
ASND Ascendis Pharma A/S 0.77%
KZR Kezar Life Sciences Inc 0.77%
PRTA Prothena Corp PLC 0.76%
ARVN Arvinas Holding 0.76%
RYTM Rhythm Pharmaceuticals Inc 0.76%
IMGN IMMUNOGEN INC 0.76%
PTGX Protagonist Therapeutics Inc 0.76%
XENE Xenon Pharmaceuticals Inc 0.76%
DCPH DCPHRA PHRMCTC 0.75%
CTMX CytomX Therapeutics Inc 0.75%
BNY MELLON CASH RESERVE USD 0.75%
ZYME ZYMEWORKS INC 0.75%
SELB Selecta Biosciences Inc 0.74%
CGEN Compugen Ltd 0.74%
BBIO BridgeBio Pharma Inc 0.74%
CRTX Cortexyme Inc 0.74%
MDGL Madrigal Pharmaceuticals Inc 0.74%
KDMN Kadmon Holdings Inc 0.74%
ALLO Allogene Therapeutics 0.74%
EIDX Eidos Therapeutics Inc 0.74%
ZIOP ZIOPHARM Oncology Inc 0.74%
XBIT XBiotech Inc 0.74%
TPTX Turning Point Therapeutics Inc 0.74%
TCDA Tricida Inc 0.74%
GOSS Gossamer Bio Inc 0.73%
ARDX Ardelyx Inc 0.73%
KURA Kura Oncology Inc 0.73%
APLS Apellis Pharmaceuticals 0.72%
FIXX Homology Medicines Inc 0.72%
CALA Calithera Biosciences Inc 0.72%
PRVL Prevail Therapeutics Inc 0.72%
DNLI Denali Therapeutics Inc 0.72%
ARNA Arena Pharmaceuticals 0.71%
RUBY Rubius Therapeutics Inc 0.71%
OYST Oyster Point Pharma Inc 0.71%
KRYS Krystal Biotech Inc 0.71%
ADAP Adaptimmune Therapeutics Plc 0.71%
YMAB Y-mAbs Therapeutics Inc 0.70%
MYOK MyoKardia Inc 0.70%
MRNA Moderna Inc 0.70%
HARP Harpoon Therapeutics Inc 0.70%
ALLK Allakos Inc 0.70%
ADVM ADVERUM BIOT O 0.69%
RIGL Rigel Pharmaceuticals Inc 0.69%
IOVA Iovance Biotherapeutics Inc 0.69%
VKTX Viking Therapeutics Inc 0.69%
PRVB Provention Bio Inc 0.68%
SWTX SpringWorks Therapeutics Inc 0.68%
PRNB Principia Biopharma Inc 0.68%
MTEM Molecular Templates Inc 0.67%
VSTM Verastem Inc 0.67%
BLUE BLUEBIRD BIO INC 0.67%
RETA Reata Pharmaceuticals Inc 0.66%
SNDX Syndax Pharmaceuticals Inc 0.66%
NGM NGM Biopharmaceuticals Inc 0.66%
MGTX MeiraGTx Holdings plc 0.65%
RLMD Relmada Therapeutics Inc 0.65%
RVMD REVOLUTION Medicines Inc 0.63%
CUE Cue Biopharma Inc 0.63%
CCXI ChemoCentryx Inc 0.63%
VIE Veolia Environnement SA 0.62%
NXTC NextCure Inc 0.61%
APLT Applied Therapeutics Inc 0.61%
KOD Kodiak Sciences Inc 0.61%
SGMO Sangamo Therapeutics Inc 0.60%
ALEC Alector 0.60%
RCUS ARCUS BIOSCIEN 0.59%
CNST Constellation Pharmaceuticals Inc 0.59%
AVRO Avrobio Inc 0.57%
ORTX Orchard Therapeutics plc 0.54%
QURE uniQure NV 0.51%
PHAT Phathom Pharmaceuticals Inc 0.46%
BBC Virtus LifeSci Biotech Clinical Trials ETF 0.00%
Cash/Cash equivalents 0.00%

BBC - Top Stories


View All BBC News

BBC - Price/Volume Stats

Current price $42.85
Prev. close $43.23
Day low $42.71
Day high $43.90
52-week high $45.70
52-week low $22.92
Day Volume 49,583
Avg. volume 36,328
Dividend yield 0.00%

BBC - Recent Returns

1-mo 5.57%
3-mo 47.81%
6-mo 14.48%
1-year 48.59%
3-year 75.17%
5-year 24.40%
YTD 12.61%
2019 63.81%
2018 -18.29%
2017 56.12%
2016 -36.63%
2015 5.25%

BBC - Stock Chart


BBC - Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular Articles



Page generated in 0.6568 seconds.